#10442 on the rich list of 14,644 insiders
Michael Secora
Chief Financial Officer at Recursion Pharmaceuticals; CFO & Chief Corp Dev Ofcr at Iambic Therapeutics. Based in San Diego, California.
$8.0M
in disclosed stock, −$379K (−4.55%) today
Live prices, last trade 3:24 PM ET
- Rank
- 10442nd of 14,644
- Companies held
- 2
- Largest holding
- RXRX, 50.2% of total
- Latest SEC filing
- Oct 16, 2026
What the $8.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals RXRX Class A Common Stock | Directly | 1,487,694 | $2.69 | $4.0M | 50.2% | Form 4, Nov 15, 2024 |
| Iambic Therapeutics IAM Common Stock | Directly | 279,902 | $14.15 | $4.0M | 49.8% | Form 4, Oct 16, 2026 |
Share counts are the amounts Michael Secora reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 10439 | Maximilian Martin Chief Executive Officer, Enhanced Group. New York, NY | $8.0M |
| 10440 | Evan Bakst Director, Alphatec Holdings. Carlsbad, CA | $8.0M |
| 10441 | Michael H. McKay Director, Construction Partners. Dothan, AL | $8.0M |
| 10442 | Michael Secora Chief Financial Officer, Recursion Pharmaceuticals. San Diego, CA | $8.0M |
| 10443 | Allan B. Hubbard Director, Simon Property Group. Indianapolis, IN | $8.0M |
| 10444 | Judy D. Olian Director, Ares Management. Los Angeles, CA | $8.0M |
| 10445 | Theresa A. Hoffer Sr Vice President - Subsidiary, Cincinnati Financial. Fairfield, OH | $8.0M |
Other Recursion Pharmaceuticals insiders
All RXRX insiders- Christopher Gibson$16.3MDirector. #5991 overall
- Blake Borgeson$16.3MDirector. #6040 overall
- Dean Y. Li$9.3MDirector. #4868 overall
- Najat Khan$5.3MCEO and President. #13846 overall
- Fred Hassan$421KDirector. #9329 overall
Questions
How much stock does Michael Secora own?
Michael Secora holds $7,955,072 in listed stock based on SEC filings and current prices, mostly Recursion Pharmaceuticals (RXRX). That ranks 10442nd on the Stock Rich List.
Is this Michael Secora's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.